An immunoperoxidase monolayer assay (IPMA) has been developed to detect antibodies against swine influenza A virus (SIV) in pig sera. The test was evaluated by using sequential sera from pigs experimentally infected with H1N1 subtype of SIV. Two hundred field serum samples that had been examined by the hemagglutination inhibition (HI) test were also tested. Antibodies specific to SIV were detected as early as 3 days postinoculation (dpi) in the IPMA test as compared with 7 dpi by the HI test. Unlike HI, no serum treatment was required in the IPMA test. Regardless of the virus used in the test, IPMA detected antibodies to both H1N1 and H3N2 subtypes of SIV whereas HI detects antibodies against either H1N1 or H3N2, depending upon the virus used in the test. Results of this study indicate that IPMA is a useful test for screening of pig sera for SIV antibodies. From the Departments of Clinical and Population Sciences (Direksin, Joo) and Veterinary Diagnostic Medicine (Goyal, Corresponding author), University of Minnesota, St. Paul, MN 55108.
Swine influenza virus (SIV) belongs to the family Orthomyxoviridae. 4 There are three types of this virus based on the antigenic relatedness of nucleoprotein (NP) and matrix (M) proteins: A, B, and C. 12 Most of the swine influenza worldwide is caused by type A, 6 which is further divided into subtypes on the basis of its hemagglutinin (HA) and neuraminidase (N) surface proteins. The predominant subtypes reported to be associated with swine influenza throughout the world are H1N1, H1N2, and H3N2. 1, 19 H1N1 has been the predominant subtype circulating in pigs in the United States. 2, 5, 14 Recently, however, H3N2 has been recovered from swine with acute clinical disease in the eastern and north central regions of the United States. 8, 18, 21, 22 Subtype H1N2 has also been isolated recently from pigs in Indiana. 7 Serological diagnosis of SIV is currently based on hemagglutination inhibition (HI) tests. Since there is no crossreaction between hemagglutinins, 2 different HI tests are used to detect antibodies against H1N1 and H3N2 subtypes of SIV. A serological test that can detect anti-NP antibody would be useful in diagnosing infection with all type A influenza viruses because NP protein is relatively conserved among various SIV strains. 19 Sensitive enzyme-linked immunosorbent assays (ELISA) have also been developed for SIV. 11, 16, 20 However, substantial amounts of purified antigens 15 or recombinant protein are needed for coating ELISA plates. 16, 20 The purpose of this study was to develop an immunoperoxidase monolayer assay (IPMA) for the detection of SIV type A antibodies and compare it to the HI tests.
Two subtypes of SIV (H1N1 and H3N2) were used in both IPMA and HI tests. A/Sw/NJ/1979/H1N1 was obtained from the National Veterinary Services Laboratories, Ames, Iowa, and A/Sw/MN/1998/H3N2 was isolated from a field sample submitted to the Minnesota Veterinary Diagnostic Laboratory (MDVL). A field isolate, A/Sw/MN/1997/H1N1, recovered from a grower pig in Minnesota was used for ex-perimental infection of pigs. Each isolate was confirmed to be H1-or H3-type by previously described method. 9 Experimental sera were produced in 5-week-old pigs. Eleven pigs were inoculated intranasally with 10 EID 50 of A/Sw/MN/1997/H1N1. Four pigs were maintained as uninoculated controls. Blood samples were collected on 0, 3, 7, 11, 14, 17, and 21 days postinoculation (dpi) and sera were tested by both HI and IPMA tests. To determine if IPMA can detect antibodies against both H1N1 and H3N2, 200 field sera were also tested. These sera were submitted to the MDVL for the detection of SIV antibodies by the HI tests.
For HI test, 100 l of each serum was heat inactivated at 56 C for 30 minutes. To remove natural nonspecific hemagglutination inhibitors, 600 l of 25% kaolin in borate saline (pH 9.0) was added to the heat-inactivated serum. This mixture was incubated at room temperature for 30 minutes and kaolin was removed by centrifugation at 3,000 ϫ g for 20 minutes. The supernatant was then mixed with 600 l of a 25% suspension of turkey red blood cells (RBC). After 2 hours of incubation at room temperature, the sera were centrifuged to remove RBC and the treated serum was considered to be at a 1:10 dilution. Serial 2-fold dilutions of treated sera were then tested by HI in 96-well microtiter plates. Briefly, serum dilution was mixed with 4 HA units of H1N1 or H3N2 and incubated at room temperature for 45 minutes. A 0.5% suspension of turkey RBC was then added. The hemagglutination reaction was read after 45 minutes incubation at room temperature.
Monolayers of Madin-Darby canine kidney (MDCK) cells were grown in 96-well microtiter plates. After washing once with Hanks balanced salt solution a containing 0.01% TPCK-treated trypsin, b the monolayers were inoculated with SIV (H1N1 or H3N2) at a multiplicity of infection of one. The plates were then incubated at 37 C in 5% CO 2 atmosphere for 48 hours, fixed in cold acetone-ethanol for 20 minutes, covered, and stored at Ϫ20 C until used (usually within 2 months of preparation).
Before adding test sera, IPMA plates were washed once with phosphate buffered saline (PBS) (pH 7.2). Serial 2-fold dilutions of sera were added to the plate (2 wells/dilution), which were incubated for 45 minutes at 37 C. After washing * H1N1 virus was used in hemagglutination inhibition (HI) and immunoperoxidase monolayer assay (IPMA). Titers of 1:10 and 1:20 were considered negative for SIV antibodies in both tests. All preinoculation sera and sera of noninfected control pigs were negative in both tests. All 28 sequential sera from 4 noninoculated control pigs were negative for SIV antibody by both IPMA and HI tests. All experimentally infected pigs developed antibody to SIV as detected by HI and IPMA (Table 1) . Sera with titers of Ͻ1:40 were considered negative in both tests. In general, IPMA was able to detect SIV antibody earlier than HI and IPMA titers were higher than HI titers (Fig. 1 ). Eight of 11 (73%) inoculated pigs became seropositive on 3 dpi by IPMA, whereas only 3 of 11 (27%) pigs seroconverted on 7 dpi when tested by HI (Table 1 ). This is in agreement with a previous study 6 in which HI detected antibodies within 5-7 dpi, with many pigs exhibiting titers of 1:80 by 1 week and 1:320-1:640 by 14-21 dpi. In another study, 10 HI titers peaked at 14-21 days after experimental infection with H1N1.
All sera from pigs experimentally infected with H1N1 were negative for H3N2 antibodies in the HI test ( Fig. 1) , whereas both H1-IPMA and H3-IPMA could detect antibodies in these pigs ( Table 2) , indicating that antibodies to SIV subtypes can cross-react in IPMA. The same was true with field sera, in which HI detected antibody to a single subtype and IPMA detected antibodies to both subtypes ( Table 2) . This is not surprising because pigs develop antibody to both internal and external proteins of SIV after natural infection 3 and IPMA detects antibodies regardless of the hemagglutinin subtype used. The ability of the HI test to detect antibody against a particular strain of SIV, on the other hand, depends on the antigenic relationship between the virus producing the antibody and the virus isolate used in the test.
The kappa coefficient was used to determine correlation among the 4 tests (H1-IPMA, H3-IPMA, H1-HI, and H3-HI) 17 and was found to be 0.80 between the 2 IPMAs for experimental sera. For H1 subtype, the agreement between the H1-HI and H1-IPMA tests was very weak (kappa coefficient ϭ 0.42), indicating that HI and IPMA may detect different isotypes of antibodies. 6 Since H1 and H3 are the most divergent from one another, with only 25% homology, 13 it is not surprising that the H1-HI test does not detect antibodies against H3N2.
The IPMA test can be used as a universal test to detect antibodies to SIV regardless of HA subtypes. If there is a need to differentiate between H1 and H3 antibodies, the respective HI tests can be run. The advantage of the IPMA test is that pretreatment of test serum is not required nor is there any need for fresh erythrocytes. Furthermore, the IPMA test can be modified to detect different isotypes (such as IgA or IgM) of immunoglobulins by simply changing the secondary antibody used in the test. In addition, the IPMA can detect SIV antibodies as early as 3 dpi, as do the highly sensitive ELISA tests. 11 However, in contrast with the ELISA test, the IPMA does not require highly purified antigen. In summary, the IPMA is a convenient alternative option for laboratories for detecting antibodies to SIV.
